https://www.zacks.com/stock/news/2218837/what-s-in-store-for-cboe-global-cboe-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-2218837
Jan 31, 2024 - Cboe Global's (CBOE) Q4 performance is likely to reflect improved transaction fees, increased demand for data and access solutions and strong proprietary products.
zc:-2003848597797433482
0
https://www.zacks.com/stock/news/2212995/here-s-why-cme-group-cme-deserves-a-spot-in-your-portfolio?cid=CS-ZC-FT-analyst_blog|rank_focused-2212995
Jan 19, 2024 - CME Group's (CME) global presence, compelling product portfolio, focus on over-the-counter clearing services and effective capital deployment poise it well for growth.
zc:3668767186749583050
0
https://www.zacks.com/stock/news/2210983/will-cme-cme-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2210983
Jan 16, 2024 - CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zc:-6214489497256519377
0
https://www.zacks.com/stock/news/2209901/zacks-industry-outlook-highlights-cme-group-intercontinental-exchange-cboe-global-markets-coinbase-global-and-marketaxess?cid=CS-ZC-FT-press_releases-2209901
Jan 15, 2024 - CME Group, Intercontinental Exchange, Cboe Global Markets, Coinbase Global and MarketAxess have been highlighted in this Industry Outlook article.
zc:7205125471010348798
0
https://www.zacks.com/stock/news/2208237/down-7-96-in-4-weeks-here-s-why-cme-cme-looks-ripe-for-a-turnaround?cid=CS-ZC-FT-tale_of_the_tape|rsi-2208237
Jan 10, 2024 - CME (CME) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
zc:-615899602298970998
0
https://www.zacks.com/stock/news/2206930/the-zacks-analyst-blog-highlights-merck-salesforce-philip-morris-international-novartis-and-cme-group?cid=CS-ZC-FT-press_releases-2206930
Jan 08, 2024 - Merck, Salesforce, Philip Morris International, Novartis and CME Group are part of the Zacks top Analyst Blog.
zc:-8865995784032994019
0
https://www.zacks.com/commentary/2206306/top-analyst-reports-for-merck-salesforce-philip-morris?cid=CS-ZC-FT-research_daily-2206306
Jan 05, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Salesforce, Inc. (CRM) and Philip Morris International Inc. (PM).
zc:-5960485884744189558
0
https://www.zacks.com/stock/news/2206293/the-zacks-analyst-blog-highlights-nvidia-coinbase-global-block-interactive-brokers-group-and-cme-group?cid=CS-ZC-FT-press_releases-2206293
Jan 05, 2024 - NVIDIA, Coinbase Global, Block, Interactive Brokers Group and CME Group are part of the Zacks top Analyst Blog.
zc:-4815769660011203106
0
https://www.fool.com/investing/2023/12/26/if-the-fed-lowers-interest-rates-in-2024-this-warr/?source=iedfolrf0000001
Dec 26, 2023 - Rising rates have been a headwind for Moody's bottom line.
0
fool:879310433968639335
0
https://www.zacks.com/stock/news/2200632/cme-group-cme-stock-surges-27-ytd-more-upside-left?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2200632
Dec 20, 2023 - CME Group's (CME) global presence, compelling product portfolio, and focus on over-the-counter clearing services and effective capital deployment poise it well for growth.
zc:-7158868889814700297
0